Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
The addition of subcutaneous daratumumab to triplet therapy improved outcomes for certain patients with newly diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback